“Upcycling” known molecules and targets for drug-resistant TB
Despite reinvigorated efforts in Tuberculosis (TB) drug discovery over the past 20 years, relatively few new drugs and candidates have emerged with clear utility against drug resistant TB. Over the same period, significant technological advances and learnings around target value have taken place. Th...
Main Authors: | Christine Roubert, Evelyne Fontaine, Anna M Upton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.1029044/full |
Similar Items
-
Antibiotic drugs targeting bacterial RNAs
by: Weiling Hong, et al.
Published: (2014-08-01) -
Phenotypic Screening in <i>C. elegans</i> as a Tool for the Discovery of New Geroprotective Drugs
by: Sven Bulterijs, et al.
Published: (2020-07-01) -
Two Decades of TB Drug Discovery Efforts—What Have We Learned?
by: Balachandra Bandodkar, et al.
Published: (2020-08-01) -
Probing the chemical–biological relationship space with the Drug Target Explorer
by: Robert J. Allaway, et al.
Published: (2018-08-01) -
Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances
by: Yuan-Chieh Yeh, et al.
Published: (2020-04-01)